ODTX 8-K 2026-09-09

Odyssey Therapeutics, Inc. (ODTX) 8-K dated 2026-09-09 — accession 0001193125-26-385477.

Odyssey Therapeutics, Inc. (ODTX) common stock.

Odyssey Therapeutics, Inc. filed a 8-K on 2026-09-09. Accession 0001193125-26-385477.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ODTX revenue for 2026-06-30 was $0. Net income was -$52.8M.

Not investment advice. The ODTX SEC hub lists recent forms. The stock page is the research view.